Related Experiment Video
Updated: Jun 13, 2026
09:16
Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
MicroRNA expression in acute myeloid leukemia
Guido Marcucci1, Michael D Radmacher, Krzysztof Mrózek
1The Comprehensive Cancer Center, The Ohio State University, A433B Starling-Loving Hall, 320 West 10th Avenue, Columbus, OH 43210, USA. guido.marcucci@osumc.edu
Current Hematologic Malignancy Reports
|April 29, 2010
Summary
MicroRNAs are newly discovered genes crucial in acute myeloid leukemia (AML) development. Their expression patterns offer new diagnostic and prognostic insights for AML patients, especially those with normal cytogenetics.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- Acute myeloid leukemia (AML) is a complex disease with diverse genetic and molecular characteristics.
- MicroRNAs (miRNAs), a class of regulatory noncoding RNAs, have emerged as significant players in myeloid leukemogenesis.
- Altered miRNA expression impacts gene regulation, influencing cancer development.
Purpose of the Study:
- To review recent research on microRNA expression alterations in AML.
- To highlight the diagnostic and prognostic significance of these miRNA changes.
- To discuss the role of miRNAs in identifying novel molecular pathways in AML.
Main Methods:
- Genome-wide analysis of microRNA expression profiles in AML patient samples.
- Correlation of miRNA signatures with cytogenetic and molecular AML subsets.
- Integration of miRNA data with existing prognostic factors (cytogenetics, gene mutations).
Main Results:
- Distinct miRNA expression signatures are associated with specific AML subtypes.
- MicroRNA profiling provides prognostic information, particularly in cytogenetically normal AML.
- Identification of previously unrecognized molecular pathways involved in leukemogenesis through miRNA studies.
Conclusions:
- MicroRNA alterations are integral to the pathogenesis of acute myeloid leukemia.
- MicroRNA expression analysis represents a valuable tool for AML diagnosis and prognosis.
- Further research into miRNA functions can uncover new therapeutic targets for AML.
Related Concept Videos
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
01:22MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...